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Conclusions: TG119 structures and plans were found to be easily 
adaptable to Delta4 phantom CT enabling a rigorous evaluation 
procedure for IMRT plans verification. Preliminary results on VMAT 
plans showed that TG119 could be a practical commissioning 
procedure for modulated arc therapy too. Delta4 allows a fast on-line 
3D dose distributions analysis substituting more traditional dosimeters 
suggested in TG119, but this solution is more expensive than the one 
proposed inside this report and it is not available in every department 
for intercomparison purposes. 
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Purpose/Objective: Quality control (QC) of volumetric modulated arc 
therapy (VMAT) delivery represents a significant additional workload 
during monthly accelerator checks. This study therefore aims to 
implement VMAT QC in as few arcs as possible using portal imaging. 
Synchronisation between gantry position, multileaf collimator (MLC) 
leaves and dose rate is the focus of the study, since this is the aspect 
which is covered least by already-implemented tests of intensity 
modulated radiation therapy (IMRT) delivery. 
Materials and Methods: An Agility accelerator with iViewGT portal 
imager (Elekta AB, Stockholm, Sweden) was used for this study. A 
steel bar of diameter 12 mm was accurately positioned in the G-T 
direction, 80 mm laterally from the isocentre (Figure 1a). An arc 
prescription was designed which irradiated the bar with a 16 mm x 
220 mm field during a complete 360° arc, so as to cast a shadow of 
the bar onto the portal imager. This resulted in a sinusoidal sweep of 
the field and shadow across the portal imager and back. The 
prescribed monitor units (MU) were chosen so as to give a uniform 
intensity during this sweep. A total of 640 MU were delivered with 
control point spacing 10°. The method was tested by simulating an 
MLC leaf position error of 2 mm at one control point, a gantry position 
error of 9° at one control point, and a dose error of 20 MU (3% of 
overall dose) at one control point. The portal images were viewed as 
integrated images. Coefficient of variation of mid-leaf profiles was 
used to evaluate the magnitude of features appearing in the portal 
images due to simulated errors. 
Results: The test requires a counter-clockwise arc and a clockwise arc 
to fully evaluate the VMAT performance of all MLC leaves. In the 
absence of simulated errors, the integrated images show uniformity. 
With simulated delivery errors, irregular patterns appear in the 
integrated portal images (Figures 1b - 1d). The increase in coefficient 
of variation relative to no delivery error is 42% due to a 2 mm MLC 
leaf position error at one control point, 108% due to a 9° gantry 
position error at one control point and 239% due to a 20 MU dose error 
at one control point. The method is more sensitive to errors at gantry 
angle 90°/270° than at 0°/180° due to the geometry of the test. 
Conclusions: This method provides fast and effective VMAT QC 
suitable for inclusion in a monthly accelerator QC programme. The 
test is able to detect errors in the delivery of individual control 
points, with the possibility of using movie images to further 
investigate suspicious image features. We are grateful for engineering 
assistance and to Elekta AB for their collaboration on VMAT and 
Agility. 
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Purpose/Objective: The predictive role of FDG-PET in identifying lung 
cancer patients at risk of relapse has opened for PET-guided 
simultaneous integrated boost (SIB), where the PET-active tumor 
region may be dose escalated [1]. Such treatment involves intensity 
modulated radiotherapy (IMRT), with a high degree of beam 
modulation, of a target positioned in the lungs. Dose calculation 
algorithms may show deficiencies under such conditions, and it is thus 
pivotal to verify whether the planned dose is correctly delivered. 
Materials and Methods: An anthropomorphic thorax phantom made of 
polystyrene (ρ=1.06,soft tissue surrogate) and polyurethane 
(ρ=0.25,lung tissue surrogate) was constructed in-house based on CT 
images of a lung cancer patient. One-hundred and one cylindrical 
cavities for alanine/EPRdosimeters (height 2.5 mm, diameter 5 mm) 
were made throughout the phantom. A SIB based on PET/CT images of 
the given patient was planned for a Varian Trilogy linear accelerator 
equipped with a 120 leaf Millennium multileaf collimator (Varian 
Medical Systems) using 6 MV photons. The IMRT boost plan objectives 
comprised, among others, a boost dose of 3.8 Gy/fraction to the FDG-
avid region including margins (biological planning volume; BTV) with 
3.1 Gy/fraction to the planning target volume (PTV, excluding the 
BTV). The IMRT plan was transferred to the anthropomorphic phantom 
where the dose distribution was calculated using the AAA algorithm in 
the Eclipse treatment planning system. Irradiation of the phantom, 
including 101 alanine/EPR dosimeters, was carried out at the linear 
accelerator in question. Phantom setup was verified with the 
accompanying OBI cone beam CT system, and portal dosimetry was 
performed for beam verification. A dosimeter calibration series with 
15 dosimeters was irradiated at the same accelerator. Readout of the 
alanine/EPR dosimeters were performed at an EleXsyS 560 Super X 
EPR spectrometer. 
Results: The phantom dose points were separated into four region 
categories; BTV, PTV (excluding BTV),lung tissue and nonspecific soft 
tissue. The mean measured versus calculated point doses within these 
regions were 3.83 vs3.84 Gy, 3.30 vs 3.29 Gy, 1.68 vs 1.63 Gy and 0.36 
vs 0.33 Gy, respectively. The mean relative difference in point doses 
(± 1 S.D.) between measurement and plan were (-0.5±1.8) %, 
(0.4±2.9) %,(5±13) % and (14±36) %, respectively. A high linear 
correlation between measured and planned doses (range 0.71-0.99) 
was seen in all regions. 
Conclusions: The PET-guided SIB can be delivered to patients with 
high dosimetric accuracy with the given planning and delivery system. 
Although some discrepancies are observed between measurements 
and calculations, these are mostly seen in non-specific soft tissue 
receiving very low doses and are most likely not clinically relevant. 
[1] van Elmpt, W., De Ruysscher, D., van der Salma,A., et al. The PET-
boost randomised phase II dose-escalation trial in non-small cell lung 
cancer. Radiother Oncol 2012; 104: 67-71. 
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Purpose/Objective: The aim of this work was to extend an EPID-based 
in-vivo dosimetry (IVD) method, developed in the last years by the 
authors for conformal radiotherapy, to step-and-shoot IMRT 
treatments of pelvic tumours. The algorithm was developed for Elekta 
linacs equipped with IviewGT EPIDs, with the aim to simplify the 
commissiong procedures and supply IVD tests in quasi-real time. 
Materials and Methods: The algorithm is based on correlation 
functions to convert EPID transit signals into in-vivo dose values, Diso, 
at the isocenter point. The EPID images were obtained by the so-
called 'IMRT Dosimetric Weighting' mode as a superposition of many 
segment fields. Each integral dosimetric image could be acquired in 
about 10 s after the end of beam delivery and could be processed 
while delivering the successive IMRT beams. A specific algorithm for 
